AVITA MEDICAL, INC. (RCEL) Free cash flow 2018–2025
AVITA MEDICAL, INC. (RCEL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.2MFY2025 · since FY2018: -$13.3M → -$32.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.2M | +44.6% |
| FY2024 | -$58.1M | -47.5% |
| FY2023 | -$39.4M | -101.6% |
| FY2022 | -$19.5M | +27.1% |
| FY2021 | -$26.8M | -14.8% |
| FY2020 | -$23.3M | -15.1% |
| FY2019 | -$20.3M | -52.1% |
| FY2018 | -$13.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice